drugset / Trial / NCT02178566

Pulmonary Rehab in Chronic Obstructive Pulmonary Disease (COPD): Response to Tyvaso

NCT02178566

Phase 2 Terminated 1 enrolled Inova Health Care Services
RandomizedParallel-groupTriple-blindTreatment

Summary

The investigators' hypothesis is that pretreating patients with COPD with inhaled treprostinil prior to pulmonary rehabilitation sessions will result in improved exercise tolerance during sessions. This in turn will lead to an increased response to pulmonary rehabilitation, resulting in improved exercise tolerance and quality of life.

Timeline

Start
2015-08
Primary completion
2019-01
Completion
2019-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Treprostinil Other / unclassified Inhaled